Forte Biosciences
FBRX
FBRX
49 hedge funds and large institutions have $306M invested in Forte Biosciences in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 19 increasing their positions, 7 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+2
Holders Change %
+4.26%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
19
Reduced
7
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
PA
Perceptive Advisors
New York
|
+$12.7M |
2 |
SCM
Suvretta Capital Management
New York
|
+$11.8M |
3 |
Invesco
Atlanta,
Georgia
|
+$10.2M |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.1M |
5 |
WP
Woodline Partners
San Francisco,
California
|
+$7M |
Top Sellers
1 |
O
OrbiMed
New York
|
-$9.04M |
2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$3.47M |
3 |
BI
BVF Inc
San Francisco,
California
|
-$2.14M |
4 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$1.51M |
5 |
EI
EAM Investors
Solana Beach,
California
|
-$1.05M |